1,2,4-triazine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjomshoa, M; Fatemi, SJ; Hadadzadeh, H; Torkzadeh-Mahani, M | 1 |
| Atlı, Ö; Demirayak, S; Ilgın, S; Yurttaş, L | 1 |
2 other study(ies) available for 1,2,4-triazine and Breast Neoplasms
| Article | Year |
|---|---|
A mononuclear Ni(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: DNA- and BSA-binding and anticancer activity against human breast carcinoma cells.
Topics: Animals; Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cattle; Coordination Complexes; DNA; Electrons; Electrophoretic Mobility Shift Assay; Ethidium; Female; Fishes; Humans; Kinetics; MCF-7 Cells; Nickel; Nucleic Acid Denaturation; Protein Binding; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Temperature; Triazines; Viscosity | 2015 |
In vitro antitumor activity evaluation of some 1,2,4-triazine derivatives bearing piperazine amide moiety against breast cancer cells.
Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Female; Humans; MCF-7 Cells; Mice; NIH 3T3 Cells; Piperazine; Piperazines; Triazines | 2014 |